Advertisement

Topics

CellAegis Devices, Inc. Company Profile

06:18 EST 16th December 2018 | BioPortfolio

CellAegis Devices, Inc., based in Toronto, Canada, is poised for EU market introduction in parallel with a broad international clinical testing program of the Company’s proprietary, automated, noninvasive autoRIC™ Device for Remote Ischemic Conditioning (RIC). Placed around the arm, CellAegis’ autoRIC Device allows for the first time, simple, consistent, reliable and cost-effective automation of RIC at the point of care, including acute care applications in the ambulance, emergency room and other hospital settings, or for chronic treatment in the home. The autoRIC Device is highly portable and time-efficient, delivering four cycles of simple-to-administer treatment in less than 40 minutes. The device is compatible with current standard-of-care treatments.


News Articles [592 Associated News Articles listed on BioPortfolio]

CellAegis Announces Completion of Patient Enrollment in UK Investigator Sponsored Clinical Trial using autoRIC® Device

TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis" or the "Company"), a commercial-stage medical device company advancing innovative, n...

[Health Policy] The need for transparency of clinical evidence for medical devices in Europe

To use medical devices rationally, health-care professionals must base their choices of which devices to recommend for individual patients on an objective appraisal of their safety and clinical effica...

FDA plans to overhaul 510(k) approval process for medical devices

The US regulator announced changes to modernize the 510(k) clearance pathway, which accounts for the majority of devices that the FDA reviews. The changes are being pursued to The post FDA plans to o...

FDA To Revamp Long-Criticized System For Approving Medical Devices

“We believe that it’s time to fundamentally modernize an approach first adopted in 1976,” FDA Commissioner Scott Gottlieb said in a statement, noting that the changes under consideration would p...

Brain Scientific launches FDA-cleared NeuroCap and Neuro diagnostic devices

The devices are held by MemoryMD, the company’s wholly-owned subsidiary. Brain Scientific unveiled the NeuroCap and NeuroEEG diagnostic devices alongside its selling partner MVAP Medical Supplies at...

Report predicts growth for wearable devices market

The worldwide market for wearable devices, including obstetric devices and wearable vital sign monitors, is expected to hit $ -More- 

Nordson buys Irish firm Clada Medical Devices

Based in Galway, Clada Medical Devices is engaged in the designing and development of balloons and balloon catheters. Terms of the deal have not been disclosed. With a The post Nordson buys Irish fir...

Global ENT Devices Market 2012-2018 Forecast to 2022: Vendor Landscape Segment Forecasts

DUBLIN, Aug 31, 2018 /PRNewswire/ -- The "ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic Devices, Surgical Read more...

PubMed Articles [727 Associated PubMed Articles listed on BioPortfolio]

Fabrication of Electrochemical-Based Bioelectronic Device and Biosensor Composed of Biomaterial-Nanomaterial Hybrid.

The field of bioelectronics has paved the way for the development of biochips, biomedical devices, biosensors and biocomputation devices. Various biosensors and biomedical devices have been developed ...

Assessment of metallic patient support devices and other items at 7-Tesla: Findings applied to 46 additional devices.

Recently, the first 7-Tesla MR system was approved for clinical use in Europe and the United States. Unfortunately, few metallic objects have undergone testing in association with this high-field-stre...

Cardiac rhythm management devices

The last decade has seen ongoing evolution and use of cardiac rhythm management devices, including pacemakers, cardiac resynchronisation therapy, implantable cardioverter defibrillators and loop recor...

The regulatory ancestral network of surgical meshes.

All surgical meshes entering the U.S. market have been cleared for clinical use by the 510(k) process of the Food and Drug Administration (FDA), in which devices simply require proof of "substantial e...

Cecal Resection with Bipolar Sealing Devices in a Rat Model.

Bipolar sealing devices are routinely used to seal blood vessels. The aim of the study is to evaluate the feasibility and safety of colonic sealing with the use of the bipolar energy devices in rats a...

Clinical Trials [1109 Associated Clinical Trials listed on BioPortfolio]

A Study of the Feasibility of Prehospital Remote Ischemic Conditioning

Prospective, single center, single arm pilot study evaluating the feasibility of delivering remote ischemic conditioning (RIC) by emergency medical services (EMS) in the prehospital settin...

Adjustment Exploratory Protocols and Functional Evaluation of New Non Invasive Devices in Healthy Volunteers

Parameters, sequences or paradigms optimisation in view of data quality and relevancy improvement.

Transvenous Lead Removal Post-Market Clinical Study

This prospective, multicenter, post-market clinical study was designed to evaluate the outcomes of lead extraction of cardiovascular implantable electronic devices (CIED) using Cook cathet...

Field Implementation of the autoRIC Device in STEMI

This is a "before and after" observational study of a therapeutic strategy to treat patients with confirmed ST-segment myocardial infarction (STEMI) with remote ischemic conditioning (RIC)...

Glottic View Using Supraglottic Devices in Pediatric Patients

Endotracheal intubation is the gold standard for securing the airway. However, while managing patients with difficult airways, various supraglottic devices have been used as rescue airway ...

Companies [1035 Associated Companies listed on BioPortfolio]

CellAegis Devices, Inc.

CellAegis Devices, Inc., based in Toronto, Canada, is poised for EU market introduction in parallel with a broad international clinical testing program of the Company’s propr...

Evergreen Medical Technologies

Evergreen Medical Technologies designs, manufactures and tests Class II and Class III medical devices for entrepreneurs, startups and established companies worldwide. Evergreen ha...

Analog Devices, Inc.

Innovation, performance, and excellence are the cultural pillars on which Analog Devices has built one of the longest standing, highest growth companies within the technology sect...

Symphonix Devices Incorporated

Hearing Devices.

Patton Medical Devices

Headquartered in Austin, Texas, Patton Medical Devices is the manufacturer of the i-port(R) Injection Port. For people taking injections who want to minimize the intrusion of injections on daily life,...

More Information about "CellAegis Devices, Inc." on BioPortfolio

We have published hundreds of CellAegis Devices, Inc. news stories on BioPortfolio along with dozens of CellAegis Devices, Inc. Clinical Trials and PubMed Articles about CellAegis Devices, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CellAegis Devices, Inc. Companies in our database. You can also find out about relevant CellAegis Devices, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record